pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, reported that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP).
The grants were awarded to PSDV to help fund further research on new generations of the company’s drug delivery technologies targeting ophthalmic diseases.
PWRM, Power3 Medical Products, Inc., PWRM.OB
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
PWRM recently reported that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Rozetta-Cell has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally.
** According to PWRM's President and Chief Scientific Officer, with the addition of Rozetta-Cell, PWRM will significantly strengthen its IP portfolio in a major growth market by merging regenerative medicine with the technologies that the company is using to identify disease-specific protein biomarkers and develop them into screening and diagnostic tests to address unmet medical needs.
More about PWRM at www.power3medical.com.
KMG Chemicals, Inc. (NASDAQ:KMGB), a global provider of specialty chemicals in carefully focused markets, reported that it has been named one of “America's 100 Best Small Companies” by Forbes magazine. KMG was ranked #35.
The entire list appears in the November 8, 2010 edition.
To qualify for the Forbes list, candidates must have sales of between $5 million and $1 billion and a stock price of $5 a share. The rankings are based on earnings growth, sales growth and return on equity in the past 12 months and over five years. Forbes also compared candidates’ stock performance with that of industry peers
Barnes & Noble, Inc. (NYSE:BKS), the world’s largest bookseller, reported the November line-up for the “More in Store™” program for the NOOK™ family of eBook Readers.
Available only in Barnes & Noble stores and only on NOOK, the free More in Store program offers NOOK customers new, exclusive content from bestselling and new authors, special offers and savings, and weekly bestseller and new release lists.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM)